PROPfizer Inc
stock28.40
+0.12 (+0.42%)
Price as of 13 Oct, 12:12 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Attractive
Attractive investment profile
Technical Analysis
Short-Term Outlook
Bearish
1 bull · 2 bear · 2 neutral
Medium-Term Outlook
Bullish
3 bull · 1 bear · 0 neutral
Price above 50-day MA
Price above 200-day MA
Price above 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD below signal line
%K below %D
Price near middle band
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+0.12
Market Cap
142771077000
Exchange
NYSE
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Pfizer Inc
What is Pfizer Inc?
Pfizer Inc. is a leading global pharmaceutical company that discovers, develops, and manufactures a wide range of medicines and vaccines. It operates through research and development, aiming to address major health challenges by creating treatments for areas like oncology, inflammation, and infectious diseases.
Is Pfizer Inc a good investment?
Pfizer is often favored by investors for its strong dividend history and stable presence in the healthcare market, though its performance can be heavily influenced by the success of its drug pipeline and patent expirations. While it offers potential for growth through medical innovation, it also faces intense regulatory scrutiny and market competition. Please note that this information is for educational purposes and does not constitute financial advice.
How do you invest in Pfizer Inc?
You can invest in Pfizer by opening an account with a brokerage platform that provides access to the New York Stock Exchange, where it trades under the ticker symbol PFE. Alternatively, you can gain indirect exposure by purchasing shares of broad healthcare exchange-traded funds or mutual funds that include Pfizer in their portfolios.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for PFE — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 13 Oct 2026Targets
No active targets — trend is consolidating.
Famous Investors Holding PFE
Ken Fisher
109.07M sh · 0.8% of portfolio
$2.63B
NEW
Ken Griffin
16.58M sh · 0.0% of portfolio
$399.31M
NEW
Ken Griffin
7.44M sh · 0.0% of portfolio
$179.05M
NEW
Michael Burry
6.00M sh · 11.1% of portfolio
$152.88M
NEW
Ken Griffin
4.96M sh · 0.0% of portfolio
$119.39M
NEW
Ken Griffin
2.50M sh · 0.0% of portfolio
$60.20M
NEW
Ken Griffin
1.23M sh · 0.0% of portfolio
$29.69M
NEW
Mario Gabelli
571.3K sh · 0.1% of portfolio
$13.76M
NEW
Ray Dalio
180.1K sh · 0.0% of portfolio
$4.34M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.